Golden Spark Corporation – Trademark Portfolio
Entity Type: 03
Golden Spark Corporation holds 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 17 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 13 are pending. Notable registered marks include AT PARTY, LL LANGMA, LANGMA CURE, GOLDEN SPARK, and LANGMA CREAM. The owner is based in CHINO, CA.
13949 RAMONA, #6J
CHINO, CA 91710
Showing of trademarks Trademarks
Trademark Classifications
Golden Spark Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Golden Spark Corporation have?
Golden Spark Corporation has 23 U.S. trademarks filed with the USPTO. Of these, 6 registered, 13 pending, 4 abandoned.
What trademark classes does Golden Spark Corporation file in?
Golden Spark Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Golden Spark Corporation's most well-known trademarks?
Golden Spark Corporation's registered trademark portfolio includes well-known marks such as AT PARTY, LL LANGMA, LANGMA CURE, GOLDEN SPARK, and LANGMA CREAM. These are among 6 currently registered trademarks in the portfolio.
What is Golden Spark Corporation's trademark registration success rate?
Golden Spark Corporation has a 60% trademark registration rate, with 6 out of 10 resolved applications resulting in successful registration. Currently, 13 applications are pending review.